Theme: Focusing on Novel Strategies in Antibiotics Research

Antibiotics 2020
Scientific Program

Renowned Speakers

Antibiotics 2020

Antibiotics 2020 invites all the participants from all over the world to attend “7th World Congress and Exhibition on Antibiotics and Antibiotic Resistance” to be held on March 16-17, 2020 | London, UK which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

We organize a series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Antibiotics 2020 is intended to honor prestigious award for talented Young researchers, Scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, junior faculty in recognition of their outstanding contribution towards the conference theme. The Young Scientist Awards make every effort in providing a strong professional development opportunity for early career academicians by meeting experts to exchange and share their experiences on all aspects of Pharmacology.

Young Research’s Awards at Antibiotics 2020 for the Nomination:

Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation and only 25 presentations acceptable at the Antibiotics 2020.

YRF Registration benefits:

  • Our conferences provide best Platform for your research through oral presentations.
  • Share the ideas with both eminent researchers and mentors.
  • Young Scientist Award reorganization certificate and memento to the winners
  • Young Scientists will get appropriate and timely information by this Forum.
  • Platform for collaboration among young researchers for better development
  • Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

YRF Registration Deadline:

Till December 30 – $399

Till January 30 – $499

Till March 15– $599

 

Why to attend?

Antibiotics 2020 is a platform to discuss and learn about the latest advancements in the field of Antibiotics and Antibiotic Resistance as the world’s consideration turned regarding the urgency of new antibiotics as the antimicrobial resistance is growing day by day. Many developed nations and International health organizations are trying to focus of the current situation and making new policies to prevent the adverse effects of Antibiotic resistance.

The 2-day conference gathers Researchers, academia, labs, Drug Manufacturers, government agencies, health professionals, hospitals, young investigators, Pharma and labs and presents their opinions through key notes, and case study presentations. This conference lays a platform for all the researchers working in the field of Antibiotics to know the latest developments and the current situation of the Antibiotic resistance problem.

Target Audience

  • Healthcare Students, Scientists, and professors
  • Doctors
  • Microbiologist
  • Infectious diseases specialists
  • Antimicrobial scientists
  • Pharmacists
  • Public health experts
  • Laboratorist
  • Bacteriology Researchers
  • Faculty of bacteriology and infectious diseases
  • Medical Colleges
  • Healthcare Associations and Societies
  • Business Entrepreneurs

Conference Opportunities

For Universities, Associations & Societies:

  • Association Partnering
  • Collaboration proposals          
  • Academic Partnering   
  • Group Participation

For Students and Research Scholars

For Business Delegates

For Product Manufacturers

  • Exhibitor and Vendor Booths
  • Sponsorships opportunities
  • Product launch
  • Workshop organizing
  • Scientific Partnering
  • Marketing and Networking with clients

After a successful conference of Antibiotics 2019, we are currently bringing forth “7th World Congress and Exhibition on Antibiotics and Antibiotic Resistance” (Antibiotics 2020) slated on March 16-17, 2020 at London, UK. Antibiotics 2020 aims to gather attendees, participants, students, and speakers, organizing committee members, delegates, most elegant societies and industries, renowned and honourable persons from top universities across the globe to London, UK. We are delighted to invite you to our 7th World Congress and Exhibition on Antibiotics and Antibiotic Resistance on March 16-17, 2020 at London, UK.

Antibiotics 2020 covers various aspects of Antibiotics, Antimicrobial Therapy, Antimicrobial Peptides, Antibiotics for Emerging & Re-Emerging Diseases, Drug Discovery Technologies in Antibiotics, Antibiotic production and Delivery method, Microorganisms Producing Antibiotics, Applications of Antibiotics, Pharmacokinetics and Pharmacodynamics of Antimicrobial drugs, Veterinary Importance of Antibiotics, Antibiotics for Oncology, Antibiotics Overuse and Resistance, Antibiotic-resistant Bacterial infections, Mechanism and Evolution of Antibiotic Resistance, Genetics of Antibiotic Resistance, Clinical Trials of Antibiotics, Clinical and Economic Burden of Antibiotic Resistance, Antibiotics: Market Analysis & Business Opportunities, Prevention and Control of Antibiotic resistance, New antibiotics and non-antibiotic approaches, Current research in antibiotic resistance, The Next Generation Approach of Antibiotics, Developing Alternatives to Antibiotics.

Track 1: Antibiotics

Antibiotics are a type of antimicrobials used in treatment and prevention of bacterial infections. They may inhibit or kill the growth of bacteria. Many antibiotics are also effective against protozoans and fungi; some are toxic to animals and humans also, even when given in therapeutic dosage. Antibiotics are not effective against viruses such as influenza or common cold, and may be harmful when taken inappropriately. Physicians must ensure the patient has a bacterial infection before prescribing antibiotics.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 2: Antimicrobial Therapy

An antimicrobial therapy kills or inhibits the growth of microorganisms such as bacteria, fungi, or protozoans. Antimicrobial agents are some of the most widely, and often used therapeutic drugs worldwide. It contributes significantly to the quality of life of many people and reduces the morbidity and mortality due to infectious disease. The remarkable success of antimicrobial therapy has been achieved with comparatively little toxicity and expense.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 3: Antimicrobial Peptides

Antimicrobial peptides (AMPs), also called Host Defence Peptides (HDPs) are part of the innate immune response found among all classes of life. AMPs have a broad spectrum of targeted organisms ranging from viruses to parasites. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as Immunomodulatory.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 4: Antibiotics for Emerging & Re-Emerging Diseases

Antimicrobial agents play vital roles in decreasing human morbidity and mortality resulting from infectious diseases. Emerging and re-emerging infectious diseases are global problems, and a constant supply of new antibiotics is essential if we are to combat these diseases successfully. The session is open to discuss on synthetic tailoring, discovery of new scaffolds, designing screens that avoid rediscovering old scaffolds, repurposing libraries of synthetic molecules for use as antibiotics, Exploring microbial niches for products, molecular target selection, improving libraries to overcome resistance, Safety and efficacy, Vaccines available for the diseases, Phage’s and parasitic bacteria, Epidemiology and spread of microbes and resistance traits.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 5: Drug Discovery Technologies in Antibiotics

Infectious diseases account for nearly one fifth of the worldwide death toll every year. The constant increase of drug‐resistant pathogens is a big challenge for treatment of infectious diseases. In addition, outbreaks of infections and new pathogens are potential threats to public health. Lack of effective treatments for drug‐resistant bacteria and recent outbreaks of Ebola and Zika viral infections have become a global public health concern. The number of newly approved antibiotics has decreased significantly in the last two decades compared with previous decades. In parallel with this, is an increase in the number of drug‐resistant bacteria. For these threats and challenges to be countered, new strategies and technology platforms are critically needed. Drug remodelling has emerged as an approach for rapid identification of effective therapeutics to treat the infectious diseases.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

 Track 6: Antibiotic production and Delivery method

Antibiotic production can be grouped into three methods: natural fermentation, semi-synthetic, and synthetic. As more and more bacteria continue to develop resistance to currently produced antibiotics, research and development of new antibiotics continues to be important. In addition to research and development into the production of new antibiotics, repackaging delivery systems is important to improving efficacy of the antibiotics that are currently produced. Improvements to this field have seen the ability to add antibiotics directly into implanted devices, aerosolization of antibiotics for direct delivery, and combination of antibiotics with non-antibiotics to improve outcomes.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 7: Microorganisms Producing Antibiotics

Antibiotic is one of the most important commercially exploited secondary metabolites produced by bacteria, fungi and Streptomyces and employed in a wide range. Most of the antibiotics used today are from the microorganisms that live in soil. Bacteria are easy to isolate, culture, maintain and to improve their strain. The main producers of the microbial metabolites, the actinobacteria, fungi and other filamentous bacteria, represent inexhaustible sources for the future.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 8: Applications of Antibiotics

Antibiotics are used commercially, potentially useful in medicine for activities other than their antimicrobial action. They are used as antitumor agents, enzyme inhibitors including powerful hypocholesterolemic agents, immunosuppressive agents, and anti-migraine agents, etc. This session mainly is to focus on the application of anti-bacterials, antifungals, and anti-cancers with their clinical use to date, including the development history, side effects, and etc. The antibiotics were classified by their uses, structure types, and molecular mechanisms.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 9: Pharmacokinetics and Pharmacodynamics of Antimicrobial drugs

The pharmacodynamics of an antimicrobial drug relates its pharmacokinetics to the time course of the antimicrobial effects at the site of the infection. Knowledge of the drug's antimicrobial pharmacodynamics effects provides a more rational basis for determination of optimal dosing regimens in terms of the dose and the dosing interval than do the minimal inhibitory concentrations (MICs) and minimal bactericidal concentrations (MBCs) determined in vitro. This session mainly focus on pharmacokinetics, antimicrobial pharmacodynamics, the effect of pharmacodynamics on the emergence of resistant bacterial subpopulations, and the development of pharmacodynamics breakpoints for use in the design of trials of these drugs and in the treatment of infected patients.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 10: Veterinary Importance of Antibiotics

Antibiotics are used in livestock production for two basic reasons: disease treatment and disease prevention. Just like humans, animals are prone to bacterial infections. As in human medicine, antibiotics are used to effectively treat those infections. In livestock production, antibiotics can also be used to prevent disease. There are times in an animal’s life, such as weaning, where certain diseases can be very common. Antibiotics are sometimes used to prevent these diseases from becoming established in the first place.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 11: Antibiotics for Oncology

An antibiotic is a chemical made by a microbe that antagonizes the growth of other cells.  They reduce the viability and clonal expansion of cancer stem cells is of broad importance, as cancer stem cells are increasingly accepted as a distinct cell type that gives rise to therapy resistance, tumour recurrence and distant metastasis. Therapeutic anticancer antibiotics have become an accepted treatment for certain types of cancer. These drugs bind specifically to primary and metastatic cancer cells to block cell growth, while limiting effects on surrounding healthy cells. Antibiotic medicines kill malignant cells by fragmenting the DNA in the cell nucleus and by oxidizing critical compounds which are necessary for the cell. Antibiotics are used against leukaemia, bladder cancer, testicular cancer, and sarcomas.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 12: Antibiotics Overuse and Resistance

Antibiotic overuse is when antibiotics are used when they're not needed. Antibiotics are one of the great advances in medicine. But overprescribing them has led to resistant bacteria (bacteria that are harder to treat). Some germs that were once very responsive to antibiotics have become more and more resistant. Antibiotic overuse is a key driver of antimicrobial resistance. Antibiotic resistance occurs when bacteria change in response to the use of these medicines. Antibiotic resistance occurs naturally, but misuse of antibiotics in humans and animals is accelerating the process. Antibiotic resistance leads to longer hospital stays, higher medical costs and increased mortality.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 13: Antibiotic-resistant Bacterial infections

Antibiotics have been used to treat people with infectious diseases caused by bacteria. However, certain antibiotics have been used so widely and for so long that some bacteria that cause disease have become resistant to them, making these treatments less effective. Antibiotic resistance occurs when the medication loses its ability to kill bacteria. As a result, the organisms continue to grow and cause infection, even in the presence of the antibiotic.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 14: Mechanism and Evolution of Antibiotic Resistance

Antibiotics target essential cellular functions but bacteria can become resistant by acquiring either exogenous resistance genes or chromosomal mutations. Resistance mutations typically occur in genes encoding essential functions; these mutations are therefore generally detrimental in the absence of drugs. However, bacteria can reduce this handicap by acquiring additional mutations, known as compensatory mutations. Genetic interactions (epistasis) either with the background or between resistances (in multiresistant bacteria) dramatically affect the fitness cost of antibiotic resistance and its compensation, therefore shaping dissemination of antibiotic resistance mutations.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 15: Genetics of Antibiotic Resistance

Acquired bacterial antibiotic resistance can result from the mutation of normal cellular genes, the acquisition of foreign resistance genes, or a combination of these two mechanisms. The most common resistance mechanisms employed by bacteria include enzymatic degradation or alteration of the antimicrobial, mutation in the antimicrobial target site, decreased cell wall permeability to antimicrobials, and active efflux of the antimicrobial across the cell membrane. The spread of mobile genetic elements such as plasmids, transposons, and integrons has greatly contributed to the rapid dissemination of antimicrobial resistance among several bacterial genera of human and veterinary importance.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 16: Clinical Trials of Antibiotics

There has been an increasing use of antibiotics in all areas of medicine. Clinical trials to test antibiotics are normally of a less than satisfactory quality. The main objective of initial clinical trials, at least, is to provide the pharmaceutical company with sufficient information to persuade the regulatory authority that the drug is effective, safe and well produced.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 17: Clinical and Economic Burden of Antibiotic Resistance

Knowledge of the clinical and economic impact of antimicrobial resistance is useful to influence programs and behaviour in healthcare facilities, to guide policy makers and funding agencies, to define the prognosis of individual patients and to stimulate interest in developing new antimicrobial agents and therapies. There are a variety of important issues that must be considered when designing or interpreting studies into the clinical and economic outcomes associated with antimicrobial resistance. One of the most misunderstood issues is how to measure cost appropriately. This session mainly focus on variety of important issues that must be considered when designing or interpreting studies of the clinical and economic outcomes associated with antimicrobial resistance.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 18: Antibiotics: Market Analysis & Business Opportunities

Antibiotic medicines are among the most prescribed courses worldwide, in fighting bacterial infections, primarily in outpatient settings. Pharmaceutical companies are actively developing analogues of existing antibiotic classes based on innovative approaches to fight bacterial infections. Key players operating in the global antibiotic market include Pfizer Inc., Astellas Pharma, Inc, Roche, Novartis AG, Bristol-Myers Squibb Co., Bayer HealthCare AG, Abbott Laboratories, MiddleBrook Pharmaceuticals, Takeda Pharmaceutical Company, Ltd., Daiichi Sankyo Company, Ltd., GlaxoSmithKline Plc, Eli Lilly and Co., and Kyorin Pharmaceutical Co., Ltd. The antibiotics market was valued at USD 39.8 billion in 2015 and is expected to witness a CAGR of 4.0% over the forecast period. Increasing efforts are being witnessed toward the development of advanced products.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 19: Prevention and Control of Antibiotic resistance  

Antimicrobial resistance is a complex problem with many diverse contributing factors. It is major cause of health concerns adding cost to oneself and to the community, directly or indirectly. Prevention is still the best tool to reduce the infection spread and thereby AMR. Along with rational use of existing antimicrobial drugs, development of new effective compounds and new diagnostic technology is the need. Joint efforts from patients, prescribers and individuals to international regulators and policy makers are needed to fight against the globally spreading antimicrobial resistance.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 20: New antibiotics and non-antibiotic approaches

New antibiotics need to be developed, which doctors will be able to use when existing drugs no longer work. Non-antibiotic treatments can also reduce our dependence on antibiotics. The government encourages companies to develop new drugs and treatments. New technologies can also help prevent infections.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 21: Current research in antibiotic resistance

Antibiotic overuse and misuse has led to a growing number of bacteria in humans, animals and the environment that are resistant to life-saving antimicrobial therapies. Urgent action is needed to halt the development of resistance, and to accelerate new treatments for bacterial infection. Research includes epidemiology of both Gram-negative and Gram-positive infections, genetic mechanisms of resistance, evolution and transmission in the hospital setting, as well as the community, and antimicrobial stewardship.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 22: The Next Generation Approach of Antibiotics

As research into antibiotic resistance expands, it is important to adopt an explicitly proactive approach to antibiotic resistance identification and surveillance, as well as antibiotic therapy development. This proactive approach involves using a combination of functional metagenomics, next-generation sequencing and cutting-edge computational methods to monitor the evolution and dissemination of resistance before a given resistance determinant emerges in a pathogen or in the clinical setting, as well as proactively developing next-generation therapies that target these resistance determinants. Recent advances in the field highlight the promise that the next generation of resistome studies hold for characterizing and countering emerging resistance threats.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 23: Developing Alternatives to Antibiotics

Alternatives to antibiotics are broadly defined as any substance that can be substituted for therapeutic drugs that are increasingly becoming ineffective against pathogenic bacteria due to antimicrobial resistance. Although antibiotics remain an essential tool for treating animal diseases on the farm, the availability of effective medical interventions to prevent and control animal diseases is one of the most significant challenges facing veterinary medicine in the 21st century. Phytochemicals as antibiotic alternatives to promote growth and enhance host health. Innovative drugs, chemicals, and enzymes within the animal production chain. Vaccines as alternatives to antibiotics for food producing animals. Also recent research provides numerous possibilities for the application nanomaterials in broad-spectrum eradication of pathogenic bacteria with many applications such as skin pathogen infection, implant sterilization, and wastewater treatment.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Antibiotics Journals

The Journal of Antibiotics | Annals of Infections and Antibiotics | Journal of Antibiotics Research | Journal of Antimicrobial Chemotherapy | Journal of Infection and Public Health | International Journal of Antibiotics | The American Journal of Medicine | International  Journal of Infectious Diseases | Stamford Journal of Microbiology | Journal of Global Antimicrobial Resistance | Journal of Pharmaceutical Sciences | International Journal of Pharmaceutics | The Pharmaceutical Journal | Pharmaceutical Research | European Journal of Pharmaceutics and Biopharmaceutics | Molecular Pharmaceutics | European Journal of Pharmaceutical Sciences | Asian Journal of Pharmaceutics | Journal of Pharmacy and Pharmacology  | Indian Journal of Pharmaceutical Sciences | Journal of Pharmacy and Pharmaceutical Sciences | Drug Development and Industrial Pharmacy | Journal of Pharmacy Practice | American Journal of Pharmaceutical Education | International Journal of Drug Development & Research | Journal of Bioequivalence & Bioavailability | Journal of Bioanalysis & Biomedicine | Journal of Pharmacogenomics & Pharmacoproteomics | Journal of Vaccines & Vaccination | Journal of Drug Metabolism & Toxicology | Drug Designing: Open Access.

Top Pharmaceutical Universities around the world:

Harvard University | University of Cambridge | University of California, San Francisco | University College London | University of North Carolina | Karolinska Institute | Yale University | King's College London | University of California, San Diego | Cardiff University | Stanford University | The Imperial College of Science, Technology and Medicine | The University of Manchester | The University of Texas | Utrecht University | The University of Dundee | Columbia University | Monash University | University of Oxford | Pierre and Marie Curie University | Medical University of Vienna | Rockefeller University | Uppsala University | University of Pennsylvania | University of Zurich | University of Tuebingen | The Ohio State University | Radboud University Nijmegen| Norwegian University of Science and Technology | Vanderbilt University | McGill University | University of Hamburg | University of Lausanne | University of Paris Descartes  | The University of Tokyo | University of California, Berkeley| Swiss Federal Institute of Technology Zurich | Kyoto University | University of Wisconsin – Madison | University of Arizona |University of South Florida | University of Utah | China Pharmaceutical University

USA Pharmaceutical Universities

University of Southern California | CUNY York College | Purdue University | University of Wisconsin-Madison | Albany College of Pharmacy and Health Sciences | University of North Carolina | University of Colorado | Oregon State University | Nova Southeastern University | Massachusetts College of Pharmacy and Health Sciences | University of Florida College of Pharmacy | University of Michigan College of Pharmacy | Campbell University School of Pharmacy | University of Pittsburgh School of Pharmacy | University of Georgia College of Pharmacy | Temple University School of Pharmacy | Ernest Mario School of Pharmacy | Skaggs School of Pharmacy | Eugene Applebaum College of Pharmacy and Health Sciences | University of North Carolina | University of Minnesota | University of California—San Francisco  | University of Michigan—Ann Arbor | University of Texas—Austin | Ohio State University | University of Illinois—Chicago | University of Kentucky | Purdue University |University of Florida | University of Maryland—Baltimore  | University of Pittsburgh  | University of Southern California |University of Washington| University of Wisconsin—Madison | University of Arizona | University of Iowa | University of Tennessee Health Science Center | University of Utah | University of Kansas | Virginia Commonwealth University | University at Buffalo | University of Colorado—Denver | Auburn University  | University of California—San Diego | University of Oklahoma | Northeastern University |

Asia Pharmaceutical Universities

University of Tokyo | National University of Singapore | Kyoto University | University of Hong Kong | Peking University | Seoul National University | National Taiwan University  | Osaka University | Tsinghua University | Chinese University of Hong Kong | Fudan University |The Hong Kong University of Science and Technology | Taipei Medical University | Mahidol University | Korea Advanced Institute of Science and Technology | Yonsei University | Shanghai Jiao Tong University | Nanyang Technological University | Chulalongkorn University | Tohoku University | Tokyo Medical and Dental University | Kyushu University | Nagoya University | Hokkaido University | Sungkyunkwan University | University of Science and Technology of China | Pohang University of Science and Technology | Korea University | University Malaya  | Indian Institute of Science

Europe Pharmaceutical Companies

Mylan | Astellas Pharma | Novo Nordisk | Boehringer Ingelheim | Allergan | Takeda | Bristol-Myers Squibb | Eli Lilly | Teva Pharmaceutical Industries | Amgen | AbbVie | AstraZeneca | GlaxoSmithKline | Gilead Sciences | Merck | Sanofi | Roche | Pfizer |  Novartis | Bayer | Johnson and Johnson | QPS | Biocrates | ThioMatrix | Polymun Scientific | Croma-Pharma | Affiris | Aposcience | EverCyte| Octapharma | Teleflex Medical | Janssen Pharmaceuticals | Lonza | Bone Therapeutics | Formac Pharmaceuticals | Oncurious | Sanofi Genzyme | Alexion | Baxter | Chemnovatic | CSL Behring | Custom Pharmaceuticals | Fujirebio Europe | Galen Limited | Martindale Pharma | Novo Nordisk A/S  | Petrone Group | Purna Pharmaceuticals  | Shire | UCB Pharma | Uni-Pharma | Covidien | Fresenius Se | Fresenius Medical | Rhoen Klinikum | Morphosys | Stada Arzneim | Carl Zeiss Meditec | Freudenberg medical | Emergent biosolutions | Aran biomedical | Norgine | Lexogen | Haplogen | Octimet Oncology | Anacura | Ablynx | Novasep | Flen Pharma | Toxikon |  Zoetis | Pharmavize | Galapagos | Eurogentec | LinaTech | Stada | Synthon | Ferring Pharmaceuticals | Lonza | UBC | Leo Pharma | Saniona | DanDrit Biotechnology | Taconic Biosciences | West Pharma

USA Pharmaceutical Companies

Gilead Sciences | Johnson & Johnson | Pfizer | Abbott Laboratories | Bristol Myers Squibb | Amgen | Biogen Idec | Celgine Corporation | Merck & Co | Eli Lilly | Acura Pharmaceuticals | Alexion Pharmaceuticals | AMRI Global | Apricus Biosciences | BioCryst Pharmaceuticals | Biovista | Ceragenix Pharmaceuticals | Coherus BioSciences | Dynax pharmaceuticals | Endo International plc| Ensemble Therapeutics | Fabre-Kramer Pharmaceuticals | Genentech | H. K. Mulford Company | Impax Laboratories | Insys Therapeutics | Jones Pharma | KaloBios Pharmaceuticals | Lexicon Pharmaceuticals | Marathon Pharmaceuticals | Meyer Brothers Drug Company | NovaBay Pharmaceuticals | Nephroceuticals | Ovation Pharmaceuticals |Peregrine Pharmaceuticals | Pharmaceutical Research and Manufacturers of America | Proteon Therapeutics | Quark Pharmaceuticals| Reliant Pharmaceuticals | Sagent Pharmaceuticals | Sucampo Pharmaceuticals | Tonix Pharmaceuticals | Verus Pharmaceuticals

Asia  Pharmaceutical Companies

3-D Matrix | Agilent | BeiGene | BioDuro | China Biological Products | Fosun Pharma | Lumenis | MicroPort | Senju Pharmaceutical | Sihuan Pharmaceutical | Sinovac Biotech | DesigneRx Pharmaceuticals | Pharmadax | Denovo Biopharma | BioMarin Pharmaceuticals | Invitrogen | WuXi Apptec | AngioDynamics | SciGenom | Dishman Specialty Chemicals | Intas Pharmaceuticals | Zydus Cadila | Advinus Therapeutics | Sigma-Aldrich | Par Pharmaceutical | Gland Pharma | Natco Pharma | Haffkine Biopharmaceuticals | Allergan | Taisho Pharmaceutical | Dainippon Sumitomo | Wakunaga Pharmaceutical | Dainippon Sumitomo | Santen | Chugai Pharma| Kissei Pharmaceutical | WaVe Life Sciences | Mitsubishi Tanabe Pharma | Astellas | Daiichi Sankyo | AnGes | Kubota Pharmaceutical | Ohara Pharmaceutical | Daewon Pharma | Charles River Laboratories | Oxonc Development | Yungjin Pharmaceutical | Neopeutics | Austrianova Biotechnology | 3M | Clinuvel Pharmaceuticals | Micropoint Technologies | Sphaera Pharma | VolitionRx | China Chemical and Pharmaceutical Company | Foresee Pharmaceuticals

African Pharmaceutical Companies

Fresenius Kabi Distribution | Luced Agencies | Akacia Health | Roche Pharmaceuticals | Biotech Laboratories  | Allied Drug Company | Janssen-cilag | Teva Pharmaceuticals | Medimoc Sarl | Bayer International Service | Boehringer Ingelheim |Columbia Pharmaceuticals | Ultimate Sport Nutrition | Astra Zeneca Pharmaceuticals | Resmed Pharmaceuticals | Servier Laboratories | Embassy Pharmaceuticals | Amalgamated Pharmaceuticals | New S Buys | Afrox Limited | Amka Pharmaceuticals | Astra Pharmaceuticals | Brunel Laboratoria | Dia-Kure Ltd | Eden Pharmaceuticals Prod | Geo Schwulst Laboratories | GM Pharmaceuticals | Hersol Manufacturing Laboratories | Intramed | Johnson & Johnson | Kyron Laboratories | Merck Generics RSA | Novo Nordisk | Pharma Natura | Pharmacare Ltd | Resmed Pharmaceuticals | S N Pharmaceuticals | Smith & Nephew Pharmaceuticals | Smithkline Beecham

Pharmaceutical Jobs

Research Associate & Research Scientist - FR&D in Trikona Pharmaceuticals Private Limited | Pharmacist - Pentagon Global Solutions Limited | QA/QC in MSN Laboratories | Sr. Executive/asst. Manager/manager-Pharma Techni in Arihant Innochem Pvt Ltd | Sr. Executive / Exe IPR Formulation- Leading Pharma in Harman Finochem Ltd | Apotex- Analytical R&D Opportunity | Junior Research Fellow in South India Textile Research Association | Research & Development (F&D) in Zim Laboratories Limited | Sr Research Associate Formulations R&D in Celon Laboratories Ltd | Sr. Officer F & D (Pharmaceutics) in SMVA Consultants | Manager in Torrel Cos. Pvt. Ltd | Quality Assurance in Suven Life Sciences Ltd | Risk Management Plan  Manager in Novartis | Associate Global Trial Director in Novartis  | Product Manager - Ophthalmology | Cardio-Diabetes for Pharma company  | Brand Manager / Product Executive in Senses pharmaceuticals ltd | Stores Clerk in Aristo Pharmaceuticals Pvt. Ltd. | Area Sales Manager in East West Pharma (Pvt) Ltd

The global antibiotics market was valued at USD 42,653.89 million in 2018, and is estimated to be valued at USD 56,369.92 million in 2024, witnessing a CAGR of 4.7%.The Antibacterial Drugs market is expected to cross US$ 38 Billion by 2024 growing at a CAGR of 1% during the given forecast period. Rising pervasiveness of irresistible illnesses particularly in creating locales, for example, Asia Pacific and MEA is foreseen to contribute towards showcase development.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players include Allergen plc, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly & Co., Forest Laboratories, Inc., GlaxoSmithKline plc, Merck & Co., Inc. Novartis AG, Pfizer, Inc., and Sanofi.

The antibiotics market generated sales of US$42 billion in 2009 globally, representing 46% of sales of anti-infective agents (which also include antiviral drugs and vaccines) and 5% of the global pharmaceutical market. However, the antibiotics market is maturing; it showed an average annual growth of 4% over the past 5 years, compared with a growth of 16.7% and of 16.4% for antiviral drugs and vaccines, respectively.     

Over 15.0% of the passing’s, in kids underneath the age of five, are assessed to be because of pneumonia and as indicated by the insights given by the WHO around 9.2 million passing’s were recorded in 2015. Like tuberculosis, the most elevated commonness of the sickness is recognized to be in the South Asian and Sub-Saharan locales. At present, the required anti-infection treatment is accessible just to 33% of the tainted populace, subsequently expanding the illness trouble.

The major driving factors of Antibacterial Drugs Market are as follows:

  • There is a very high prevalence of infectious diseases.
  • The research and development activities have increased.
  • Product differentiation through various methods.
  • Increased government support.

The restraining factors of Antibacterial drugs Market is as follows:

  • Rise in drug resistant species.
  • Launch of the generic drugs.
  • Patent expiry

Importance and Scope

Antibiotic resistance is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases. A growing list of infections such as pneumonia, tuberculosis, blood poisoning, gonorrhoea, and foodborne diseases are becoming harder, and sometimes impossible, to treat as antibiotics become less effective.

Where antibiotics can be bought for human or animal use without a prescription, the emergence and spread of resistance is made worse. Similarly, in countries without standard treatment guidelines, antibiotics are often over-prescribed by health workers and veterinarians and over-used by the public. Without urgent action, we are heading for a post-antibiotic era, in which common infections and minor injuries can once again kill.

Target Audience

Related Companies

  1. Gilead Sciences
  2. Pfizer
  3. Abbott Laboratories
  4. Merck & Co
  5. Eli Lilly
  6. Astellas Pharma
  7. Teva Pharmaceutical Industries
  8. Boehringer Ingelheim
  9. Roche
  10. Mylan
  11. 3-D Matrix
  12. Agilent
  13. BeiGene
  14. BioDuro
  15. Fosun Pharma

Related Associations and Societies

  1. World Health Organization
  2. U.S. Food and Drug Administration (FDA)
  3. Natural Resources Defense Council (NRDC)
  4. Infectious Diseases Society of America
  5. World Health Assembly
  6. Center for a Livable Future (CLF)
  7. The Humane Society of the United States (HSUS)
  8. Alliance for the Prudent Use of Antibiotics
  9. Civil Society Organisations
  10. British Society for Antimicrobial Chemotherapy
  11. Pediatric Infectious Diseases Society
  12. Royal Society of Medicine
  13. European Society of Clinical Microbiology and Infectious Diseases
  14. CAESAR (Central Asian & Eastern European Surveillance of Antimicrobial Resistance)
  15. WAAAR - World Alliance Against Antibiotic Resistance
  16. ReAct – Action on Antibiotic Resistance
  17. American Medical Association

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date March 16-17, 2020
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2
Poster Opportunity Closed Click Here to View

Media Partners